The predictors of lung injury during durvalumab maintenance therapy following concurrent chemoradiotherapy in unrescectable locally advanced non-small cell lung carcinoma - Milan 2023

Untangling the molecular footprints in lung cancer diagnosis and treatment

Chair(s): Maria Joana Pereira Catarata, Rainer G. Wiewrodt

Session type: Oral presentation

The predictors of lung injury during durvalumab maintenance therapy following concurrent chemoradiotherapy in unrescectable locally advanced non-small cell lung carcinoma

Nobuyuki Hirama

EVENTS HOME

Previous presentation

Next presentation

Session content

Integrated multi-omics unraveled a basal cell-dependent signature predictor of outcome and immunotherapy response in LUSC

Jianlong Jia

Replay

Poster

Abstract

Slides

1G6-D7 regulates the extracellular heat shock protein 90 involved in DNA damage repair affecting tumor immunity in non-small cell lung cancer

Jiangzhou Du

Replay

Poster

Abstract

Slides

IL-17A induces EGFR-targeted therapy resistance via enhancing EGFR activation in lung cancer

Kai Ling Lee

Replay

Poster

Abstract

Slides

Validation of a 5-gene signature for predicting outcomes in early-stage NSCLC patients

Rui Reis

Replay

Poster

Abstract

Slides

The role of CD137-CD137L and CD200-CD200L pathways in the regulation of tumor immune microenvironment.

Iwona Kwiecien

Replay

Poster

Abstract

Slides

Reproducibility of a 12-gene set for predicting outcome and benefit from ACT in early-stage NSCLC patients

Rui Reis

Replay

Poster

Abstract

Slides

Circulating extracellular vesicles in the identification of immune checkpoint associated with lung cancer

Maureen Cambier

Replay

Poster

Abstract

Slides

The predictors of lung injury during durvalumab maintenance therapy following concurrent chemoradiotherapy in unrescectable locally advanced non-small cell lung carcinoma

Nobuyuki Hirama

Replay

Poster

Abstract

Slides

Discussion and Q&A

Replay

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}